Kulvindar Kaur, MD, posted this on Twitter.
New Covid Pre-print: Drs Ioannidis & Axfors at Stanford Age Infection Survival Rate 0-19 99.9973% 20-29 99.986% 30-39 99.969% 40-49 99.918% 50-59 99.73% 60-69 99.41% 70+ 97.6% (non-inst.) 70+ 94.5% (all)
https://www.medrxiv.org/content/10.1101/2…
New Covid Pre-print:
Drs Ioannidis & Axfors at Stanford
Age Infection Survival Rate
0-19 99.9973%
20-29 99.986%
30-39 99.969%
40-49 99.918%
50-59 99.73%
60-69 99.41%
70+ 97.6% (non-inst.)
70+ 94.5% (all)
https://www.medrxiv.org/content/10.1101/2021.07.08.21260210v1?fbclid=IwAR1XH5v8Gba-ZAxMb5LzTwfZfL7ogEpH7qgeaF3cU2djC2gAwcanIRWMdYk
undefined subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.
Kulvindar Kaur, MD, posted this on Twitter.
New Covid Pre-print:
Drs Ioannidis & Axfors at Stanford
Age Infection Survival Rate
0-19 99.9973%
20-29 99.986%
30-39 99.969%
40-49 99.918%
50-59 99.73%
60-69 99.41%
70+ 97.6% (non-inst.)
70+ 94.5% (all)
https://www.medrxiv.org/content/10.1101/2021.07.08.21260210v1?fbclid=IwAR1XH5v8Gba-ZAxMb5LzTwfZfL7ogEpH7qgeaF3cU2djC2gAwcanIRWMdYk